170 related articles for article (PubMed ID: 33308239)
1. Quality assessment of the guidelines for the management of malignant pleural effusions and ascites.
Li JX; Shi YM; An LY; Yang JX; Qi YX; Yang T; Cen YY; Lin YY; Sun DL
World J Surg Oncol; 2020 Dec; 18(1):331. PubMed ID: 33308239
[TBL] [Abstract][Full Text] [Related]
2. A benchmarking project on the quality of previous guidelines about the management of malignant pleural effusion from the European Society of Thoracic Surgeons (ESTS) Pleural Diseases Working Group.
Bertolaccini L; Bedetti B; Brunelli A; Marinova K; Raveglia F; Rocco G; Shargall Y; Solli P; Varela G; Papagiannopoulos K; Kuzdzal J; Massard G; Ruffini E; Falcoz PE; Martinez-Barenys C; Opitz I; Batirel HF; Toker A; Scarci M;
Eur J Cardiothorac Surg; 2017 Aug; 52(2):356-362. PubMed ID: 28402401
[TBL] [Abstract][Full Text] [Related]
3. Management of Malignant Pleural Effusions-What Is New.
Thomas R; Roy B; Maldonado F; Lee YCG
Semin Respir Crit Care Med; 2019 Jun; 40(3):323-339. PubMed ID: 31525808
[TBL] [Abstract][Full Text] [Related]
4. Successful use of indwelling tunneled catheters for the management of effusions in children with advanced cancer.
den Hollander BS; Connolly BL; Sung L; Rapoport A; Zwaan CM; Grant RM; Parra D; Temple MJ
Pediatr Blood Cancer; 2014 Jun; 61(6):1007-12. PubMed ID: 24376007
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of human type 5 recombinant adenovirus (H101) in malignant tumor with malignant pleural effusion and ascites: A multicenter, observational, real-world study.
Wang B; Zhong C; Liao Z; Wang H; Cai X; Zhang Y; Wang J; Wang T; Yao H
Thorac Cancer; 2023 Oct; 14(30):3051-3057. PubMed ID: 37675621
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of malignant pleural effusions.
Heffner JE
Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
[TBL] [Abstract][Full Text] [Related]
7. Management of malignant pleural effusions and ascites.
Covey AM
J Support Oncol; 2005; 3(2):169-73, 176. PubMed ID: 15796449
[No Abstract] [Full Text] [Related]
8. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the diagnosis and management of malignant pleural effusions.
Heffner JE; Klein JS
Mayo Clin Proc; 2008 Feb; 83(2):235-50. PubMed ID: 18241636
[TBL] [Abstract][Full Text] [Related]
10. Current practices in the management of malignant pleural effusions: a survey among members of the European Society of Thoracic Surgeons.
Scarci M; Caruana E; Bertolaccini L; Bedetti B; Brunelli A; Varela G; Papagiannopoulos K; Kuzdzal J; Massard G; Ruffini E; Falcoz PE; Opitz I; Batirel H; Toker A; Rocco G;
Interact Cardiovasc Thorac Surg; 2017 Mar; 24(3):414-417. PubMed ID: 28040756
[TBL] [Abstract][Full Text] [Related]
11. Malignant pleural effusion cell blocks are substitutes for tissue in EML4-ALK rearrangement detection in patients with advanced non-small-cell lung cancer.
Zhong J; Li X; Bai H; Zhao J; Wang Z; Duan J; An T; Wu M; Wang Y; Wang S; Wang J
Cytopathology; 2016 Dec; 27(6):433-443. PubMed ID: 27060609
[TBL] [Abstract][Full Text] [Related]
12. Current controversies in the management of malignant pleural effusions.
Azzopardi M; Porcel JM; Koegelenberg CF; Lee YC; Fysh ET
Semin Respir Crit Care Med; 2014 Dec; 35(6):723-31. PubMed ID: 25463163
[TBL] [Abstract][Full Text] [Related]
13. Malignant Pleural Effusion and Its Current Management: A Review.
Skok K; Hladnik G; Grm A; Crnjac A
Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31443309
[TBL] [Abstract][Full Text] [Related]
14. Management of malignant pleural effusions.
Spector M; Pollak JS
Semin Respir Crit Care Med; 2008 Aug; 29(4):405-13. PubMed ID: 18651358
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of nutrition care procedures in nutrition guidelines for cancer patients.
Zhao XH; Yang T; Ma XD; Qi YX; Lin YY; Chen XZ; Duan YQ; Sun DL
Clin Nutr; 2020 Jun; 39(6):1692-1704. PubMed ID: 31542246
[TBL] [Abstract][Full Text] [Related]
16. Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.
Zhu J; Feng M; Liang L; Zeng N; Wan C; Yang T; Shen Y; Wen F
BMC Cancer; 2017 Aug; 17(1):590. PubMed ID: 28854885
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic Natural Killer Subpopulations as a Prognostic Factor of Malignant Pleural Effusion.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2019 Feb; 197(1):53-60. PubMed ID: 30523401
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
[TBL] [Abstract][Full Text] [Related]
20. Malignant pleural effusions.
Putnam JB
Surg Clin North Am; 2002 Aug; 82(4):867-83. PubMed ID: 12472134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
